rs397517040
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397517040
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs727503106
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs121913529
|
|
|
0.790 |
GeneticVariation |
BEFREE |
NSCLC cell lines with mutant KRas-Gly12Asp had activated phosphatidylinositol 3-kinase (PI-3-K) and mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) signaling, whereas those with mutant KRas-Gly12Cys or mutant KRas-Gly12Val had activated Ral signaling and decreased growth factor-dependent Akt activation.
|
22247021 |
2012 |
rs121913530
|
|
|
0.800 |
GeneticVariation |
BEFREE |
NSCLC cell lines with mutant KRas-Gly12Asp had activated phosphatidylinositol 3-kinase (PI-3-K) and mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) signaling, whereas those with mutant KRas-Gly12Cys or mutant KRas-Gly12Val had activated Ral signaling and decreased growth factor-dependent Akt activation.
|
22247021 |
2012 |
rs121913529
|
|
|
0.790 |
GeneticVariation |
BEFREE |
A biopsy acquired after disease progression revealed the original SDC4-ROS1 fusion along with a KRAS point mutation (p.G12D).We reviewed the related literature to determine the frequency of gene mutations in non-small cell lung cancer patients.
|
28971587 |
2018 |
rs121913529
|
|
|
0.790 |
GeneticVariation |
BEFREE |
A doxycycline-inducible mouse model of KRAS (G12D) driven NSCLC and patient data was analyzed from multiple publicly accessible databases including TCGA, CCLE, NCBI GEO and Project Achilles.
|
26173780 |
2015 |
rs121913529
|
|
A |
0.790 |
GeneticVariation |
CLINVAR |
A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.
|
20609353 |
2010 |
rs61761074
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among them, rs61761074 demonstrated a significant correlation with allele frequency in non-small-cell lung cancer (NSCLC).
|
26648033 |
2015 |
rs121913530
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913530
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913530
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913529
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913529
|
|
G |
0.790 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs17851045
|
|
G |
0.720 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs17851045
|
|
A |
0.720 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913535
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913535
|
|
G |
0.710 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913535
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs112445441
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs112445441
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913238
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913240
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913240
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913530
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |